Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.59 USD | -2.53% | -1.53% | -10.00% |
01/05 | RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept | MT |
30/04 | Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.00% | 6.45B | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Guggenheim Raises Exelixis' Price Target to $30 From $27, Keeps Buy Rating